Abaxis, Inc. to Present at Needham & Company's Twelfth Annual Growth Stock Conference

Jan 05, 2010, 07:00 ET from Abaxis, Inc.

UNION CITY, Calif., Jan. 5 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer will present at Needham & Company's Twelfth Annual Growth Stock Conference on Thursday, January 14, 2010 at 10:00 a.m. ET. The conference will be held at The New York Palace Hotel in New York City.

About Abaxis

Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.



    Contact: Clint Severson          Lytham Partners, LLC
             Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum
             ABAXIS, Inc.            602-889-9700
             510-675-6500


SOURCE Abaxis, Inc.